🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Neutrophil Phenotypic Profiling and Organ Injury Assessment in Patients With Sepsis

Recruitingn/aAges 1 Month - 17 YearsAllBoston Children's Hospital
NCT04103268 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In this research study we want to learn more about the character of neutrophils that are present in the blood of children with sepsis. Sepsis is a severe type of infection, affecting various parts of the body. Neutrophils are a type of white blood cell that are part of the body's immune system. Even though neutrophils are important in getting rid of germs, they also may be harmful to parts of the body by causing injury in organs in patients with sepsis. Neutrophils can change their character in sepsis. Because of this, it is important for doctors to know what kind of neutrophils are in the blood of children with sepsis so that they can work to develop therapies to prevent these cells from being harmful.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion criteria Patients will be eligible for enrollment as septic patients if they * Are \< 18 years old * Meet the definition of sepsis described in the study design section above. Patients will be eligible for enrollment as control patients if they * Are \< 18 years old * Are scheduled for an elective surgical procedure and need preoperative blood draw or will have an intravenous catheter placed for the purpose of their surgical procedure. Exclusion criteria Patients will be ineligible for enrollment in either control or sepsis group if any of the followings is present or anticipated * Congenital cardiac disease * On chronic immunosuppressive drugs such as chronic corticosteroid use, or preexisting immunodeficiency diseases
💊

What it tests

  • sepsis
📍

Where

1 site
Boston Children's Hospital
Boston, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy